Johnson & Johnson MedTech Executive and Leadership Team

Tino Schweighoefer, the Chief Financial Officer, Monarch Platform at Johnson & Johnson MedTech, manages the fiscal health and investment strategy for the advanced robotics and intervention platform. Schweighoefer oversees capital allocation to ensure that research and development efforts remain aligned with long-term growth objectives. By analyzing market trends in medical technology, the Chief Financial Officer, Monarch Platform optimizes resource distribution to accelerate the deployment of robotic surgical solutions. This role requires close collaboration with engineering teams to balance innovation costs with revenue targets. Tino Schweighoefer monitors financial performance metrics to ensure that the Monarch platform maintains a competitive edge in the global healthcare landscape. Through rigorous financial oversight, the Chief Financial Officer, Monarch Platform secures the necessary funding to scale operations and expand the reach of these critical medical interventions across diverse clinical environments.

Gigi Chang, the Chief Financial Officer, Medtech (Canada) at Johnson & Johnson MedTech, governs all financial operations and regulatory compliance within the Canadian market. Chang directs budgeting processes and financial reporting to ensure alignment with the broader corporate strategy of the organization. By evaluating regional market dynamics, the Chief Financial Officer, Medtech (Canada) identifies opportunities for cost optimization and revenue growth within the medical device portfolio. This leadership position involves managing relationships with local stakeholders and ensuring that financial practices adhere to strict healthcare industry standards. Gigi Chang provides critical insights that inform strategic decision-making regarding the distribution of medical technology solutions across the region. Through meticulous financial planning, the Chief Financial Officer, Medtech (Canada) supports the company's mission to deliver high-quality healthcare interventions while maintaining fiscal stability and operational efficiency in the Canadian market.

Paolo Di Vincenzo, the Global President, Trauma at Johnson & Johnson MedTech, leads the development and commercialization of advanced orthopedic trauma solutions. Di Vincenzo oversees the entire product lifecycle, from initial engineering design to global market distribution. By focusing on clinical needs, the Global President, Trauma ensures that the company provides surgeons with the most effective tools for complex bone repair and reconstruction. This leadership role involves managing international teams to drive growth in North American and European markets. Paolo Di Vincenzo collaborates with medical professionals to refine device performance and improve patient recovery outcomes. Through strategic market expansion, the Global President, Trauma strengthens the company's position as a leader in orthopedic intervention. By prioritizing innovation and quality, the Global President, Trauma ensures that the trauma portfolio remains at the forefront of medical technology, consistently meeting the rigorous demands of modern surgical practice.

Sharrolyn Josse, the Global President Joint Reconstruction- Hips, Knees and Shoulders at Johnson & Johnson MedTech, directs the strategy and innovation for the joint replacement division. Josse oversees the design and manufacturing of high-performance implants that restore mobility to patients worldwide. By analyzing clinical data and surgical trends, the Global President Joint Reconstruction- Hips, Knees and Shoulders ensures that the product line addresses the specific needs of orthopedic surgeons. This role involves managing global supply chains to maintain consistent availability of critical surgical components. Sharrolyn Josse leads cross-functional teams to advance the technology behind hip, knee, and shoulder reconstruction, focusing on durability and patient comfort. Through strategic partnerships with healthcare providers, the Global President Joint Reconstruction- Hips, Knees and Shoulders drives market adoption of advanced reconstruction solutions. By maintaining a focus on engineering excellence, the Global President Joint Reconstruction- Hips, Knees and Shoulders supports the company's mission to improve quality of life through medical intervention.

Edward Zhou, the President (China) at Johnson & Johnson MedTech, manages all commercial operations and strategic growth initiatives within the Chinese market. Zhou oversees the distribution of medical devices and the implementation of healthcare technology solutions tailored to local clinical requirements. By navigating the complex regulatory landscape, the President (China) ensures that the company maintains a strong presence in one of the world's largest healthcare markets. This leadership role involves building relationships with regional hospitals and medical institutions to promote the adoption of advanced surgical tools. Edward Zhou directs local teams to optimize sales performance and improve service delivery across the region. Through strategic planning, the President (China) aligns local operations with the global mission of the company. By fostering innovation and operational excellence, the President (China) drives significant growth and ensures that the company remains a trusted partner for medical professionals throughout China.

Steven Henn, the Global President, Biosurgery at Johnson & Johnson MedTech, leads the development and global strategy for advanced hemostasis and tissue sealing technologies. Henn oversees the research and manufacturing processes that produce critical solutions for surgical bleeding control. By focusing on the intersection of biology and engineering, the Global President, Biosurgery ensures that the company provides surgeons with reliable tools for complex procedures. This role involves managing international commercial teams to expand the reach of biosurgical products in hospitals across North America and Asia. Steven Henn collaborates with clinical experts to identify emerging needs in surgical intervention and to drive product innovation. Through rigorous quality control and strategic market positioning, the Global President, Biosurgery maintains the company's leadership in the biosurgery sector. By delivering high-impact solutions, the Global President, Biosurgery supports the company's commitment to improving surgical outcomes and patient safety on a global scale.

Sarah Najdek, the President, Surgery (Asia Pacific) at Johnson & Johnson MedTech, directs the commercial strategy and operational execution for the surgical division across the Asia Pacific region. Najdek oversees the deployment of advanced medical devices and surgical platforms to meet the diverse needs of healthcare systems in the area. By analyzing regional market trends, the President, Surgery (Asia Pacific) identifies opportunities for growth and ensures that the company provides high-quality support to surgical teams. This leadership role involves managing cross-functional teams to optimize the supply chain and improve product accessibility. Sarah Najdek fosters collaboration with local medical leaders to advance the adoption of innovative surgical technologies. Through strategic market development, the President, Surgery (Asia Pacific) strengthens the company's footprint in the region. By prioritizing clinical excellence and operational efficiency, the President, Surgery (Asia Pacific) ensures that the company remains a key contributor to the advancement of surgical care in Asia Pacific.

Devi Govender, the Worldwide President of Heart Recovery at Johnson & Johnson MedTech, leads the global strategy and innovation for cardiac support and recovery technologies. Govender oversees the development of advanced devices designed to assist heart function during critical interventions. By focusing on the integration of engineering and clinical expertise, the Worldwide President of Heart Recovery ensures that the company provides life-saving solutions to patients worldwide. This role involves managing international research and development teams to drive the next generation of heart recovery technology. Devi Govender collaborates with cardiologists and surgeons to refine device performance and improve patient outcomes. Through strategic market expansion, the Worldwide President of Heart Recovery strengthens the company's position in the cardiovascular sector. By maintaining a commitment to innovation and quality, the Worldwide President of Heart Recovery supports the company's mission to transform medical intervention capabilities and improve long-term heart health for patients across the globe.

Sword Zheng, the Chief Human Resources Officer at Johnson & Johnson MedTech, directs all talent acquisition and organizational development initiatives. Zheng architects comprehensive workforce strategies that align human capital with the complex manufacturing requirements of medical device production. By fostering a culture of innovation, the Chief Human Resources Officer ensures that the company attracts top-tier engineering and clinical talent. This leadership role involves managing global performance frameworks that support the diverse operational needs across North America and international markets. Through the implementation of advanced training programs, Sword Zheng strengthens the internal capabilities required to maintain market leadership in healthcare technology. Ultimately, the Chief Human Resources Officer drives organizational agility, ensuring that the workforce remains prepared to meet the evolving demands of the medical technology sector while maintaining high standards of operational excellence.

Yvan Francois, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech at Johnson & Johnson MedTech, coordinates strategic initiatives across the global supply chain and executive leadership functions. Francois facilitates communication between the Executive Vice President and various operational departments to ensure seamless execution of corporate objectives. By streamlining internal processes, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech enhances the efficiency of the worldwide supply chain, ensuring that medical devices reach clinical settings without delay. This role involves managing complex projects that span multiple international regions, requiring a deep understanding of global logistics and manufacturing. Yvan Francois monitors progress on key performance indicators to ensure that the organization meets its strategic goals. Through effective coordination, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech drives operational alignment and supports the company's commitment to medical innovation.